About Gene Logic
Gene Logic is a company based in Gaithersburg (United States) founded in 1994. Gene Logic has raised $29 million across 2 funding rounds from investors including Goldman Sachs, Hambrecht & Quist and Oxford Bioscience Partners. Gene Logic operates in a competitive market with competitors including Human Longevity, GSK, Avidity Biosciences, Helix and Benchling, among others.
- Headquarter Gaithersburg, United States
- Stage Public
- SectorsHealthcareTechnology
- Website genelogic.com
- Social LinkedIn
- Legal Name Gene Logic Acquisition Corp.
- Total Equity Funding$29M (USD)
in 2 rounds
- Latest Funding Round$20M (USD), Series B
Jul 1997
- InvestorsGoldman Sachs
& 3 more
Funding Insights of Gene Logic
Gene Logic has successfully raised a total of $29M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in July 1997. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29M
- Total Rounds 2
- Last Round Series B — $20M
- First Round $9M
(May 1996)
- Investors Count 4
All 2 funding rounds of Gene Logic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 1997 | $20M | Series B | – | – | |
| May 1996 | $9M | Series A | – | – |
4 investors in total: 4 institutional.
Investors in Gene Logic
Gene Logic has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Hambrecht & Quist and Oxford Bioscience Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
Early stage VC firm investing in the US and Korea | – | oxbio.com | Boston, United States | |
- | – | genechem.com | - | |
- | – | hamquist.com | - |
Investor details for Gene Logic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Gene Logic
4 dated milestones of Gene Logic across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Gene Logic is founded.
- Funding First funding round of $9.0M.
- Funding Latest funding round, Series B, of $20.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Gene Logic
Gene Logic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Human Longevity, GSK, Avidity Biosciences, Helix and Benchling, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| humanlongevity.com | 2013 | San Diego, United States | $408.72M | 83 | Genomics data and cell therapy-based diagnostic and therapeutic solutions | |
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of Gene Logic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gene Logic
Websites that share an audience with Gene Logic (genelogic.com).
Websites whose visitors overlap most with Gene Logic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
iivs.org | iivs.org | 100% | – | #4,426,493 | – |
| kpl.com | 100% | – | – | View details | |
| trevigen.com | 100% | – | – | View details | |
| genologics.com | 100% | – | – | View details | |
| invitrogen.com | 97% | 5.2K | #3,688,642 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Gene Logic
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Gene Logic
Complete news archive for Gene Logic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Gene Logic
10 companies that operate in the same segment as Gene Logic (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gene Logic
Gene Logic was founded in 1994 and raised its 1st funding round 2 years after it was founded.
Gene Logic is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Gene Logic is a funded company, having raised a total of $29M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9M, raised on May 1996.
Gene Logic was founded in 1994 in Gaithersburg, United States, as an integrated genomics firm. Comprehensive genomic reference databases and GLP-compliant microarray services were offered, alongside drug development solutions for the pharmaceutical sector. Involvement in the clinical-stage small molecule candidate GL1001, repositioned for gastrointestinal disease treatment, was noted. The genomic business was acquired by Ocimum Biosolutions in 2007.
Gene Logic's top competitors include Sutro Biopharma, Synthego and Helix.
Gene Logic has 4 investors. Key investors include Goldman Sachs, Hambrecht & Quist, Oxford Bioscience Partners, and Genechem.
Gene Logic operates through Gene Logic Acquisition Corp..